Microalbuminuria: a valid marker for cardiovascular disease

As we aim to improve the identification and therapeutic management of those at highcardiovascular risk, certain less traditional risk markers are being more closely investigated.With growing evidence to support its relation to risk, microalbuminuria is becoming morewidely recognised as an important marker in this assessment. Dr Paul Newman examines theevidence and seeks to rationalise a valid therapeutic strategy for high risk patients.